Search

Search results

915 results found

Large-scale circulating proteome association study (CPAS) meta-analysis identifies circulating proteins and pathways predicting incident hip fractures.

Austin, Thomas R, Howard A Fink, Diana I Jalal, Anna E Törnqvist, Petra Buzkova, Joshua I Barzilay, Tianyuan Lu, et al. 2024. “Large-Scale Circulating Proteome Association Study (CPAS) Meta-Analysis Identifies Circulating Proteins and Pathways Predicting Incident Hip Fractures.”. Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research.

Cardiac MR Characterization of Myocardial Tissue Injury in a Miniature Swine Model of Cancer Therapy-related Cardiovascular Toxicity.

Nakata, Kei, Selcuk Kucukseymen, Xiaoying Cai, Tuyen Yankama, Jennifer Rodriguez, Eiryu Sai, Patrick Pierce, et al. 2024. “Cardiac MR Characterization of Myocardial Tissue Injury in a Miniature Swine Model of Cancer Therapy-Related Cardiovascular Toxicity.”. Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance, 101033.

Heterogeneity in the Prevalence of Cardiovascular Risk Factors by Ethnicity and Birthplace Among Asian Subgroups: Evidence From the 2010 to 2018 National Health Interview Survey.

Lim, Arum, Sabrina Elias, Chitchanok Benjasirisan, Samuel Byiringiro, Yuling Chen, Ruth-Alma Turkson-Ocran, Cheryl R Dennison Himmelfarb, Yvonne Commodore-Mensah, and Binu Koirala. 2024. “Heterogeneity in the Prevalence of Cardiovascular Risk Factors by Ethnicity and Birthplace Among Asian Subgroups: Evidence From the 2010 to 2018 National Health Interview Survey.”. Journal of the American Heart Association 13 (5): e031886.

Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.

Faridi, Kamil F, Jordan B Strom, Harun Kundi, Neel M Butala, Jeptha P Curtis, Qi Gao, Yang Song, et al. 2023. “Association Between Claims-Defined Frailty and Outcomes Following 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.”. Journal of the American Heart Association 12 (14): e029588.